QHSLab Announces New Strategic Alliance with Medical License Factory For its AllergiEnd® Products and Services
24 juin 2022 08h30 HE
|
QHSLab, Inc.
This Partnership Expands QHSLab’s Independent Practitioner Network, While Addressing Current Industry Pain Points. WEST PALM BEACH, FL, June 24, 2022 (GLOBE NEWSWIRE) -- QHSLab, Inc. (OTCQB:...
QHSLab, Inc’s CEO Addresses Current Market Conditions & Recent Quarterly Performance
24 mai 2022 08h00 HE
|
QHSLab, Inc.
WEST PALM BEACH, FL, May 24, 2022 (GLOBE NEWSWIRE) -- QHSLab, Inc. (OTCQB: USAQ) a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through...
New $90 million annual addressable market for QHSLab’s latest product, the Allergy Quick Test, branded AllergiQT™.
10 mai 2022 08h30 HE
|
QHSLab, Inc.
WEST PALM BEACH, FL, May 10, 2022 (GLOBE NEWSWIRE) -- QHSLab, Inc. (OTCQB: USAQ) a company focused on providing clinicians with tools to leverage proactive, value-based healthcare solutions through...
QHSLab. Issues Update and Investor Presentation May 2022
09 mai 2022 08h30 HE
|
QHSLab, Inc.
Superior Business Model and Strategic Position Validated By Repeat Ordering Client Base and New Developments to Product Portfolio Addressable Market Opportunity Includes Over 250,000...
USA Equities Corp (USAQ) Announces Name Change to QHSLab, Inc.
19 avr. 2022 08h30 HE
|
QHSLab, Inc.
The name change comes from the strong brand recognition garnered by the company’s flagship product, QHSLab WEST PALM BEACH, FL, April 19, 2022 (GLOBE NEWSWIRE) -- USA Equities Corp (USAQ: OTCQB)...
USA Equities Corp. Reports Fourth Quarter and Full Year 2021 Financial Results
05 avr. 2022 08h00 HE
|
USA Equities Corp
Fourth Quarter 2021 Revenue Up 265% ●Revenue Surpassed $1.4 million for the year ended 2021 Compared to $124,000 for 2020●Gross Margin of 52% in Q4 Increased 1,200 Basis Points Versus Q4 2020●Strong...
QHSLab Expands Digital Prescription Product Portfolio in 2022
16 févr. 2022 08h00 HE
|
USA Equities Corp
The company is introducing additional point-of-care digital healthcare and clinical decision-making tools into the market throughout the coming year.A major milestone includes the launch of the...
USA Equities Corp's QHSLab Digital Health Platform Strategy is Backed by Latest Research Published in the Journal of the American Medical Association (JAMA)
07 janv. 2022 08h30 HE
|
USA Equities Corp
The JAMA research found that digital health interventions supporting patient self-management improves primary care for patients with multiple chronic conditions.QHSLab supports medical decision making...
USA Equities Corp. Introduces AllergiQT™ – Quick Test, Further Expanding Market Presence
29 nov. 2021 08h00 HE
|
USA Equities Corp
FDA-cleared and Easily Administered Skin Test for Environmental and Food Allergens; AllergiQT™ – Quick Test Targets Non-Allergy Specialists in Primary Care SettingsStrengthens USA Equities...
USA Equities Corp. Announces Third Quarter 2021 Financial Results And Conversion of Secured Convertible Promissory Note
16 nov. 2021 07h30 HE
|
USA Equities Corp
● Revenue Surpassed $1 million for Nine Months of 2021 Compared to $0 for the Same Period 2020 ● Gross Margin of 48% in Q3 Increased 290 Basis Points Versus Q2 2021 ● Issuance of 76,923 Shares...